Literature DB >> 10620525

The p53 heterozygous knockout mouse as a model for chemical carcinogenesis in vascular tissue.

N G Carmichael1, E L Debruyne, D Bigot-Lasserre.   

Abstract

Heterozygous p53 knockout mice were investigated as a potential model for vascular tumor carcinogenesis. Groups of 20 male mice were exposed by gavage for 6 months to the vascular carcinogen urethane at 1, 10, or 100 mg/kg body weight/day. Wild-type and heterozygous p53 knockout control groups were exposed by gavage to the vehicle alone. Another group of 20 male mice received d-limonene by gavage (d-limonene is noncarcinogenic in mice). The high dose of urethane caused early mortality in the majority of mice associated with histopathologic evidence of toxicity and tumors, including a high incidence of benign and malignant vascular tumors, in all animals. At the intermediate dose, toxicity was less marked and 3 of 20 mice had tumors; mice that received the low dose did not have signs of toxicity or neoplasia. The two control groups had no tumors and the d-limonene group had one tumor of the prostate, which was considered spontaneous. We conclude that the p53 knockout mouse is a useful tool for investigating vascular tumorogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620525      PMCID: PMC1637864          DOI: 10.1289/ehp.0010861

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  21 in total

1.  p53 gene mutation pattern in rat liver tumors induced by vinyl chloride.

Authors:  A Barbin; O Froment; S Boivin; M J Marion; F Belpoggi; C Maltoni; R Montesano
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

Review 2.  The carcinogenic action and metabolism of urethan and N-hydroxyurethan.

Authors:  S S Mirvish
Journal:  Adv Cancer Res       Date:  1968       Impact factor: 6.242

3.  Tumor promotion in the forestomach epithelium of mice by oral administration of citrus oils.

Authors:  W E Field; F J Roe
Journal:  J Natl Cancer Inst       Date:  1965-11       Impact factor: 13.506

4.  A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice.

Authors:  C J Nicol; M L Harrison; R R Laposa; I L Gimelshtein; P G Wells
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

5.  Ethylcarbamate in fermented beverages and foods. I. Naturally occurring ethylcarbamate.

Authors:  C S Ough
Journal:  J Agric Food Chem       Date:  1976 Mar-Apr       Impact factor: 5.279

Review 6.  d-limonene mechanistic data and risk assessment: absolute species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion.

Authors:  J Whysner; G M Williams
Journal:  Pharmacol Ther       Date:  1996       Impact factor: 12.310

Review 7.  The p53-deficient mouse: a model for basic and applied cancer studies.

Authors:  L A Donehower
Journal:  Semin Cancer Biol       Date:  1996-10       Impact factor: 15.707

8.  The significance of mouse liver tumor formation for carcinogenic risk assessment: results and conclusions from a survey of ten years of testing by the agrochemical industry.

Authors:  N G Carmichael; H Enzmann; I Pate; F Waechter
Journal:  Environ Health Perspect       Date:  1997-11       Impact factor: 9.031

Review 9.  Alternatives to the 2-species bioassay for the identification of potential human carcinogens.

Authors:  J Ashby
Journal:  Hum Exp Toxicol       Date:  1996-03       Impact factor: 2.903

10.  p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain.

Authors:  H Nishino; A Knöll; V L Buettner; C S Frisk; Y Maruta; J Haavik; S S Sommer
Journal:  Oncogene       Date:  1995-07-20       Impact factor: 9.867

View more
  4 in total

1.  ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.

Authors:  Stephanie E Busch; Kay E Gurley; Russell D Moser; Christopher J Kemp
Journal:  J Pathol       Date:  2012-05-08       Impact factor: 7.996

2.  Effects of Repeated Anesthesia Containing Urethane on Tumor Formation and Health Scores in Male C57BL/6J Mice.

Authors:  Tonia S Rex; Kelli Boyd; Troy Apple; Courtney Bricker-Anthony; Krystal Vail; Jeanne Wallace
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

Review 3.  The use of genetically modified mice in cancer risk assessment: challenges and limitations.

Authors:  David A Eastmond; Suryanarayana V Vulimiri; John E French; Babasaheb Sonawane
Journal:  Crit Rev Toxicol       Date:  2013-09       Impact factor: 5.635

Review 4.  The role of transgenic mouse models in carcinogen identification.

Authors:  John B Pritchard; John E French; Barbara J Davis; Joseph K Haseman
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.